New Leaf Venture Partners is a venture capital firm in New York focused on investments in healthcare technology companies. Founded 2005 in New York, United States by James Niedel, Jeani Delagardelle, Philippe Chambon, Ronald Hunt, and Vijay Lathi, this venture capital firm invests in debt, early stage ventures, late stage ventures and private equity. Its portfolio companies include Iterum Therapeutics, Aptinyx, Kyruus, AiCure, and Edgewise Therapeutics. As of February 2020, New Leaf Venture Partners has made 155 investments. Their most recent investment was on Nov 7, 2019, when AiCure raised $24.5M. New Leaf Venture Partners has had 39 exits, the most notable of which include Alector, Aptinyx, and Wave Life Sciences. The company has raised four funds, their latest being New Leaf Ventures IV. The company specifically focuses on later stage biopharmaceutical products, early stage medical devices, and laboratory infrastructure technologies.
Timeline
Funded Companies
AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.
U.S-based company providing a platform to match patients with the right healthcare personnel.
A company developing products to treat respiratory diseases, including chronic obstructive pulmonary disease
A technology company offering an internet of things (IoT) platform for the biopharmaceutical and medical technology industries.
Kit Check is a Washington, D.C.-based provider of a cloud software platform for automated hospital pharmacy and medication processing and tracking.
A company developing diagnostic monitoring solutions for early diagnosis and treatment of cardiac arrhythmia
A company developing treatments for genetic disorders associated with the liver
A company that provides cell and tissue based diagnostic tests for personalized medicine development
A medical device company designing and developing products for patients with psychiatric disorders
Nested is a London-based company founded by Matt Robinson, James Turford and Phil Cowans.
A biopharmaceutical company developing drugs to treat cardiovascular and renal diseases
Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases.
Passage Bio, Inc is a Philadelphia-based biotechnology company developing genetics-based medicines.
TigerConnect is a healthcare focused secure communication and messaging company.
Edgewise Therapeutics is a drug discovery and biotechnology company developing products based on the understanding of skeletal muscle.
A biopharmaceutical company developing oral small molecule therapies for the treatment of cancer and autoimmune diseases
DiCE Molecules is a Redwood City, California-based company.
Access Closure is a Santa Clara, California-based healthcare company.
CardioKinetix is a Menlo Park, California-based company.
IlluminOss Medical is a East Providence, Rhode Island-based healthcare company founded by Arnold Peter Weiss.
People
Christina Kim
Analyst
Dan Becker
Principal
Philippe Chambon
Managing Director and founder
Rebecca Luse
Vice President
Ron Hunt
Managing Director
Further reading
Documentaries, videos and podcasts
Companies
AiCure
BrightInsight
CuraSen Therapeutics
Edgewise Therapeutics
Harpoon Therapeutics
Passage Bio
Qlaris Bio
Renovacor
TigerConnect
News
References
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Marie Gabrielle Laguna- Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur - 2
Reys Phillips
A graduate of Cleveland State University with a Bachelor of Science in Education. My main hobbies include story writing and reading. - 3
Aime Anne Nisay
QA Engineer of web and mobile applications - 4
Henry Ogolla
Passionate about reading and writing. - 5
Carla Faraguna
Golden People and Operations.